Warning letter
MYA International, Inc.: warning letter of Feb 24, 2022
FDA warning letter 619877 · Office of Human and Animal Food Operations –West Division 5
Key facts
| Reference number | 619877 |
|---|---|
| Company | MYA International, Inc. |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Feb 24, 2022 |
| Posted date | May 3, 2022 |
| Issuing office | Office of Human and Animal Food Operations –West Division 5 |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.70(e), 101, 101.4, 101.7, 101.36, 111, 111.260, 101.2(e), 101.3(d), 101.4(h)(1), 101.5(d), 101.36(b)(3)(iv) and 28 more |
| Inspection city | Chula Vista |
| Inspection ZIP | 91911 |
| Inspection start date | Aug 30, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: